S100 blood concentrations in children subjected to cardiopulmonary by-pass.

S100 is a member of a family of calcium-binding proteins present primarily in nervous tissue, where it is mainly concentrated in glial cells (1)(2). Although the role of this protein in brain function and disease has not yet been conclusively elucidated, it has been ascertained that the appearance of this protein constituent of neural cells in biological fluids is a reliable indicator of active cell damage in the nervous system in different pathological conditions (3)(4)(5)(6). Open heart surgery is known to be associated with brain cell injury. It was diagnosed previously using rather crude psychometric tests and clinical observations in seemingly healthy patients (7), and measurements of S100 in the blood have recently been successfully used to monitor cerebral damage after cardiac surgery (8)(9)(10). The present study is aimed at investigating the potential use of measurements of S100 in the blood to monitor possible cerebral distress during extracorporeal circulation in children (0–9 years), when hemodynamic adaptive phenomena in the brain show peculiarities linked to the age of the patient (11). The data presented indicate significantly higher blood concentrations of this nervous tissue constituent during cardiopulmonary by-pass (CPB), together with a direct relationship with the duration of CPB. Blood samples were taken from 13 patients (6 males and 7 females), ages from <1 year to 9 years (two patients <1 year of age, one 1 year of age, six 3 years of age, one 4 years of age, one 5 years of age, and two 9 years of age), with no preexisting neurological disorders or other co-morbidities, who were undergoing cardiac …

[1]  B. Romner,et al.  Age- and Sex-Related Changes of S-100 Protein Concentrations in Cerebrospinal Fluid and Serum in Patients with No Previous History of Neurological Disorder , 1997 .

[2]  D. Taggart,et al.  Comparison of Serum S-100β Levels During CABG and Intracardiac Operations , 1997 .

[3]  C. Alling,et al.  Serum S100 protein: a potential marker for cerebral events during cardiopulmonary bypass. , 1996, The Annals of thoracic surgery.

[4]  A. Lindgren,et al.  Cerebral complications after cardiac surgery assessed by S-100 and NSE levels in blood. , 1995, Journal of cardiothoracic and vascular anesthesia.

[5]  G. Borm,et al.  Cerebrospinal neuron‐specific enolase, S‐100 and myelin basic protein in neurological disorders , 1995, Acta neurologica Scandinavica.

[6]  T. Åberg Signs of brain cell injury during open heart operations: past and present. , 1995, The Annals of thoracic surgery.

[7]  S. Fulle,et al.  The S-100: A protein family in search of a function , 1995, Progress in Neurobiology.

[8]  J. Alksne,et al.  A comparison of the effects on neuronal Golgi morphology, assessed with electron microscopy, of cardiopulmonary bypass, low-flow bypass, and circulatory arrest during profound hypothermia. , 1992, The Journal of thoracic and cardiovascular surgery.

[9]  H. Hårdemark,et al.  S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. , 1987, Stroke.

[10]  A. Keats,et al.  Etiologic Factors in Neuropsychiatric Complications Associated with Cardiopulmonary Bypass , 1982, Anesthesia and analgesia.

[11]  F. Michetti,et al.  The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system , 1980, Journal of the Neurological Sciences.

[12]  F. Michetti,et al.  The nervous system-specific S-100 antigen in cerebrospinal fluid of multiple sclerosis patients , 1979, Neuroscience Letters.

[13]  J. Malm,et al.  Psychiatric complications of open-heart surgery. , 1965, The New England journal of medicine.